Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 29Recruiting 22Completed 10Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Recurrent Head and Neck Carcinoma 1

Interventions

Specimen Handling 35Magnetic Resonance Spectroscopy 23Biopsy 22Cyclophosphamide 11venetoclax 7Nivolumab 6Azacitidine 6pembrolizumab 5Taxes 5Etoposide 5Cisplatin 5Bevacizumab 5fludarabine phosphate 4fludarabine 4X-Rays 4Vincristine 4Surgical Procedures, Operative 4Radiosurgery 4Radiation 4Gemcitabine 4Doxorubicin 4Cetuximab 4130-nm albumin-bound paclitaxel 4durvalumab 3decitabine and cedazuridine drug combination 3cemiplimab 3Tacrolimus 3Surveys and Questionnaires 3Radiotherapy, Intensity-Modulated 3Prednisone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Proton Therapy × 1 year × Clear all
NCT03164460 2026-03-20

Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck Cancer

M.D. Anderson Cancer Center

Phase 2 Suspended
68 enrolled
Head & Neck

Recurrent Head and Neck Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡